Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 4 OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration Resistant Prostate Cancer (mCRPC) 1

Interventions

Cyclophosphamide 2042 Radiotherapy 1859 Cisplatin 1825 Carboplatin 1533 Gemcitabine 1434 Paclitaxel 1289 Bevacizumab 1270 Docetaxel 1202 pembrolizumab 1199 Oxaliplatin 1160 Capecitabine 1144 Fluorouracil 1061 Dexamethasone 971 Rituximab 919 Nivolumab 908 Magnetic Resonance Spectroscopy 862 Etoposide 839 Doxorubicin 823 Drug Therapy 792 Radiosurgery 776 Irinotecan 775 Cytarabine 736 fludarabine 716 Leucovorin 676 Lenalidomide 608 fludarabine phosphate 564 Temozolomide 552 Radiation 541 Filgrastim 540 Cetuximab 537

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × CX 5461 × Clear all

NCT05425862 2023-12-11

REPAIR

Peter MacCallum Cancer Centre, Australia

Phase 1 Suspended

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡